共 30 条
Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation
被引:76
作者:
Aversa, A.
[1
]
Pili, M.
Francomano, D.
Bruzziches, R.
Spera, E.
[2
]
La Pera, G.
[3
]
Spera, G.
机构:
[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Chair Internal Med, DFM, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Urol, Rome, Italy
[3] Azienda Osped San Camillo, Rome, Italy
关键词:
phosphodiesterase type-5 inhibitor;
IELT;
PERT;
ejaculatory control;
treatment;
PHOSPHODIESTERASE TYPE-5 INHIBITORS;
SEMINAL-VESICLE TISSUE;
REFRACTORY TIME;
DRUG-TREATMENT;
SILDENAFIL;
EFFICACY;
DEFINITION;
VALIDATION;
TADALAFIL;
RESPONSES;
D O I:
10.1038/ijir.2009.21
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Premature ejaculation (PE) is thought to be the most common male sexual dysfunction; however, the prevalence of lifelong (LL)-PE is relatively low. The aim of this study was to investigate the effects of on-demand vardenafil (10 mg) to modify the intravaginal ejaculatory latency time (IELT) in men with LL-PE without erectile dysfunction. Forty-two men (18-35 years) were enrolled in a 16-week, double-blind, placebo-controlled, cross-over study. Primary end point was the modification from baseline of IELT assessed by stopwatch technique; secondary end points were post-ejaculatory refractory time (PERT) and variations of scores at the Index of Premature Ejaculation questionnaire. The changes in geometric mean IELT were superior after taking vardenafil (0.6 +/- 0.3 vs 4.5 +/- 1.1 min, P < 0.01), compared with placebo (0.7 +/- 0.3 vs 0.9 +/- 1.0 min, ns). PERT dropped significantly after vardenafil (16.7 +/- 2.0 vs 4.3 +/- 0.9 min, P < 0.001), compared with placebo (15.3 +/- 2.2 vs 15.8 +/- 2.3 min). Patients who took vardenafil (vs placebo) reported significantly (P < 0.01) increased ejaculatory control (6 +/- 2 vs 16 +/- 2), improved overall sexual satisfaction (7 +/- 2 vs 15 +/- 1) and distress (4 +/- 1 vs 8 +/- 1) scores, respectively. Multiple regression analysis (r(2) = 0.86) for IELT by the number of attempts at sexual intercourse showed significant differences between the slopes of lines for placebo and vardenafil (P < 0.0001). The most common adverse events for vardenafil (vs placebo) were headache (10 vs 3%), flushing (12 vs 0%) and dyspepsia (10 vs 0%), which tended to disappear over the time. In conclusion, in our study, vardenafil increased IELT and reduced PERT in men with LL-PE. Besides, improvements in confidence, perception of ejaculatory control and overall sexual satisfaction were reported. International Journal of Impotence Research (2009) 21, 221-227; doi: 10.1038/ijir.2009.21; published online 28 May 2009
引用
收藏
页码:221 / 227
页数:7
相关论文